Search research articles
Contact Us
Filters
Showing results (451-460 of 679) with videos related to
Page
of 68
Sort By:
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
January 1, 1985
Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes
P D Riben, G B Horsman, E Rayner, et al.
Molecules (Basel, Switzerland)
|
June 2, 2021
Droplet Microfluidic Optimisation Using Micropipette Characterisation of Bio-Instructive Polymeric Surfactants
Charlotte A Henshaw, Adam A Dundas, Valentina Cuzzucoli Crucitti, et al.
The New England Journal of Medicine
|
February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators
B G Feagan, J Rochon, R N Fedorak, et al.
Biomaterials
|
September 8, 2004
The influence of dispersant concentration on the pore morphology of hydroxyapatite ceramics for bone tissue engineering
L A Cyster, D M Grant, S M Howdle, et al.
Science (New York, N.Y.)
|
August 3, 2023
Human STING is a proton channel
Bingxu Liu, Rebecca J Carlson, Ivan S Pires, et al.
Parasite Immunology
|
December 1, 1995
Regulation of egg production, worm burden, worm length and worm fecundity by host responses in sheep infected with Ostertagia circumcincta
M J Stear, S C Bishop, M Doligalska, et al.
Biomaterials
|
September 1, 2020
Discovery of hemocompatible bacterial biofilm-resistant copolymers
Taranjit Singh, Andrew L Hook, Jeni Luckett, et al.
Journal of Pharmaceutical Sciences
|
July 22, 2025
Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP)
Sammaiah Pallerla, Ivan S Pires, Mariane B Melo, et al.
The Journal of Clinical Investigation
|
May 5, 2015
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C Hanson, Monica P Crespo, Wuhbet Abraham, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2024
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
Malte Roerden, Andrea B Castro, Yufei Cui, et al.
Page
of 68
Search research articles
Search
Showing results (451-460 of 679) with videos related to
Sort By:
Page
of 68
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
January 1, 1985
Emergence of tobramycin-resistant S. epidermidis possessing aminoglycoside modifying enzymes and bacteremic superinfection during empiric therapy of febrile neutropenic episodes
P D Riben, G B Horsman, E Rayner, et al.
Molecules (Basel, Switzerland)
|
June 2, 2021
Droplet Microfluidic Optimisation Using Micropipette Characterisation of Bio-Instructive Polymeric Surfactants
Charlotte A Henshaw, Adam A Dundas, Valentina Cuzzucoli Crucitti, et al.
The New England Journal of Medicine
|
February 2, 1995
Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators
B G Feagan, J Rochon, R N Fedorak, et al.
Biomaterials
|
September 8, 2004
The influence of dispersant concentration on the pore morphology of hydroxyapatite ceramics for bone tissue engineering
L A Cyster, D M Grant, S M Howdle, et al.
Science (New York, N.Y.)
|
August 3, 2023
Human STING is a proton channel
Bingxu Liu, Rebecca J Carlson, Ivan S Pires, et al.
Parasite Immunology
|
December 1, 1995
Regulation of egg production, worm burden, worm length and worm fecundity by host responses in sheep infected with Ostertagia circumcincta
M J Stear, S C Bishop, M Doligalska, et al.
Biomaterials
|
September 1, 2020
Discovery of hemocompatible bacterial biofilm-resistant copolymers
Taranjit Singh, Andrew L Hook, Jeni Luckett, et al.
Journal of Pharmaceutical Sciences
|
July 22, 2025
Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP)
Sammaiah Pallerla, Ivan S Pires, Mariane B Melo, et al.
The Journal of Clinical Investigation
|
May 5, 2015
Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants
Melissa C Hanson, Monica P Crespo, Wuhbet Abraham, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2024
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
Malte Roerden, Andrea B Castro, Yufei Cui, et al.
Page
of 68